Accenture Launches Pharmaceutical Industry R&D Services Suite; David Boath Comments

accenture logoAccenture has introduced new research and development services intended to help pharmaceutical companies deliver medical products to patients.

The company has invested more than $200 million in the Accelerated R&D Services suite that works to integrate research and development tasks for customers using cloud, mobility and analytics platforms, Accenture said Wednesday.

Services aim to help clients market pharmaceutical products through a pay-for-performance structure for business process outsourcing.

“An industry demand exists for new benchmarks that are driven by increasingly stringent health authority requirements, unsustainable fixed-cost models, and the complexity of managing numerous vendor partners and technology systems,” said David Boath, senior managing director of the suite for Accenture.

Boath added the new suite aims to complement Accenture’s acquisition of Octagon Research Solution, its recent evaluation by IDC Health Insights Drug Safety Services for clinical and pharmacovigilance operations and collaborations with cloud companies.

Accenture seeks to help customers identify patients, capture trial data and centralize data and reporting through the Clinical Data Interchange Standards Consortium criteria.

Cloud-based regulatory services use the CDISC standards and a unified processing platform to help clients manage regulatory quality and operations.

Pharmacovigilance services also work to build on mobile and web-based information for compliance.

email
Filed in: Healthcare IT Tags: , , , , , , ,

You might like:

General Dynamics Captures NSA Secure Mobile Contract; Chris Marzilli Comments General Dynamics Captures NSA Secure Mobile Contract; Chris Marzilli Comments
Frost & Sullivan: Government Set for Wound Care Market Innovation, Growth Frost & Sullivan: Government Set for Wound Care Market Innovation, Growth
Praescient Analytics: Data Analysis, Social Media, Crowdsourcing Key in Anti-Ebola Effort Praescient Analytics: Data Analysis, Social Media, Crowdsourcing Key in Anti-Ebola Effort
LexisNexis Surveys Consumer Willingness to Share Personal Data with Industries, Gov’t; Dennis Becker Comments LexisNexis Surveys Consumer Willingness to Share Personal Data with Industries, Gov’t; Dennis Becker Comments
© 2014 ExecutiveBiz. All rights reserved.